UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Diabetes care, 2007-09, Vol.30 (9), p.2277-2280

2007

Volltextzugriff (PDF)

Impact of Glycemic Control on Neonatal Outcome in Singleton Pregnancies Complicated by Gestational Diabetes

Diabetes care, 2007-03, Vol.30 (3), p.467-470

2007

Volltextzugriff (PDF)

Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery

American journal of obstetrics and gynecology, 2011-09, Vol.205 (3), p.275.e1-275.e5

2011

Volltextzugriff (PDF)

Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?

American journal of obstetrics and gynecology, 2007-09, Vol.197 (3), p.260.e1-260.e4

2007

Volltextzugriff (PDF)

Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate

American journal of obstetrics and gynecology, 2007-03, Vol.196 (3), p.224.e1-224.e4

2007

Volltextzugriff (PDF)

Elective delivery at 340/7 to 366/7 weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension

American journal of obstetrics and gynecology, 2011, Vol.204 (1), p.44.e1-44.e5

2011

Volltextzugriff (PDF)

Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011

American journal of perinatology, 2012-09, Vol.29 (8), p.635-642

2012

Volltextzugriff (PDF)

Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes

Journal of women's health (Larchmont, N.Y. 2002), 2008-09, Vol.17 (7), p.1183-1187

2008

Volltextzugriff (PDF)

The reliability of patient-reported pregnancy outcome data

Population health management, 2010-02, Vol.13 (1), p.27-32

2010

Volltextzugriff (PDF)

Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice

The journal of maternal-fetal & neonatal medicine, 2010-10, Vol.23 (10), p.1139-1142

2010

Volltextzugriff (PDF)

Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance

Journal of reproductive medicine, 2009-02, Vol.54 (2), p.47

2009

Volltextzugriff (PDF)

Management of recurrent preterm labor in twin gestations with nifedipine tocolysis

American journal of perinatology, 2008-10, Vol.25 (9), p.555-560

2008

Volltextzugriff (PDF)

Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study

American journal of perinatology, 2010-02, Vol.27 (2), p.157-162

2010

Volltextzugriff (PDF)

A Randomized Multicenter Study to Determine the Efficacy of Activity Restriction for Preterm Labor Management in Patients Testing Negative for Fetal Fibronectin

Journal of Perinatology, 2005-10, Vol.25 (10), p.626-630

2005

Volltextzugriff (PDF)

The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation

American journal of perinatology, 2009-02, Vol.26 (2), p.123-128

2009

Volltextzugriff (PDF)

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Obstetrical & gynecological survey, 2008-02, Vol.63 (2), p.72-74

2008

Volltextzugriff (PDF)

Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery

The journal of maternal-fetal & neonatal medicine, 2007-03, Vol.20 (3), p.249-252

2007

Volltextzugriff (PDF)

Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations

Journal of perinatology, 2001-10, Vol.21 (7), p.444-450

2001

Volltextzugriff (PDF)

Excessive uterine contractions: effect on the incidence of preterm delivery in twin gestation

Journal of reproductive medicine, 2005-12, Vol.50 (12), p.923

2005

Volltextzugriff (PDF)

Consequences of nonindicated preterm delivery in singleton gestations

Journal of reproductive medicine, 2003-09, Vol.48 (9), p.713

2003

Volltextzugriff (PDF)

Home subcutaneous metoclopramide therapy for hyperemesis gravidarum

Journal of perinatology, 2000-09, Vol.20 (6), p.359-362

2000

Volltextzugriff (PDF)

A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations

Journal of perinatology, 2000-10, Vol.20 (7), p.408-413

2000

Volltextzugriff (PDF)

Monitored outpatient management of mild gestational hypertension remote from term in teenage pregnancies

American journal of obstetrics and gynecology, 1995-12, Vol.173 (6), p.1865-1868

1995

Volltextzugriff (PDF)

Elective delivery at 34 0/7 to 36 6/7 weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension

American journal of obstetrics and gynecology, 2011, Vol.204 (1), p.44.e1-44.e5

2011

Volltextzugriff (PDF)

Reply

American journal of obstetrics and gynecology, 2008-02, Vol.198 (2), p.244-245

2008

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(45)
magazinearticle
(3)

Sprache

Englisch
(48)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Impact of Glycemic Control on Neonatal Outcome in Singleton Pregnancies Complicated by Gestational Diabetes

Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery

Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?

Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate

Elective delivery at 340/7 to 366/7 weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension

Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011

Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes

The reliability of patient-reported pregnancy outcome data

Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice

Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance

Management of recurrent preterm labor in twin gestations with nifedipine tocolysis

Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study

A Randomized Multicenter Study to Determine the Efficacy of Activity Restriction for Preterm Labor Management in Patients Testing Negative for Fetal Fibronectin

The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery

Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations

Excessive uterine contractions: effect on the incidence of preterm delivery in twin gestation

Consequences of nonindicated preterm delivery in singleton gestations

Home subcutaneous metoclopramide therapy for hyperemesis gravidarum

A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations

Monitored outpatient management of mild gestational hypertension remote from term in teenage pregnancies

Elective delivery at 34 0/7 to 36 6/7 weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension

Reply

Suchergebnisse filtern